#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=The development of nanostructures that mimic the remarkable functions and catalytic properties of natural enzymes , i. e. , to create nanozymes , has been an exciting topic in the field of nanotechnology for the last two decades .
3-1	17-20	The	abstract[3]	new[3]	coref	3-26[9_3]
3-2	21-32	development	abstract[3]	new[3]	_	_
3-3	33-35	of	abstract[3]	new[3]	_	_
3-4	36-50	nanostructures	abstract[3]|object	new[3]|new	_	_
3-5	51-55	that	_	_	_	_
3-6	56-61	mimic	_	_	_	_
3-7	62-65	the	abstract[5]	new[5]	_	_
3-8	66-76	remarkable	abstract[5]	new[5]	_	_
3-9	77-86	functions	abstract[5]	new[5]	_	_
3-10	87-90	and	_	_	_	_
3-11	91-100	catalytic	abstract[6]	new[6]	_	_
3-12	101-111	properties	abstract[6]	new[6]	_	_
3-13	112-114	of	abstract[6]	new[6]	_	_
3-14	115-122	natural	abstract[6]|substance[7]	new[6]|new[7]	_	_
3-15	123-130	enzymes	abstract[6]|substance[7]	new[6]|new[7]	_	_
3-16	131-132	,	abstract[6]	new[6]	_	_
3-17	133-135	i.	abstract[6]	new[6]	_	_
3-18	136-138	e.	abstract[6]	new[6]	_	_
3-19	139-140	,	_	_	_	_
3-20	141-143	to	_	_	_	_
3-21	144-150	create	_	_	_	_
3-22	151-160	nanozymes	object	new	coref	4-7[14_0]
3-23	161-162	,	_	_	_	_
3-24	163-166	has	_	_	_	_
3-25	167-171	been	_	_	_	_
3-26	172-174	an	abstract[9]	giv[9]	_	_
3-27	175-183	exciting	abstract[9]	giv[9]	_	_
3-28	184-189	topic	abstract[9]	giv[9]	_	_
3-29	190-192	in	abstract[9]	giv[9]	_	_
3-30	193-196	the	abstract[9]|abstract[10]	giv[9]|new[10]	_	_
3-31	197-202	field	abstract[9]|abstract[10]	giv[9]|new[10]	_	_
3-32	203-205	of	abstract[9]|abstract[10]	giv[9]|new[10]	_	_
3-33	206-220	nanotechnology	abstract[9]|abstract[10]|abstract	giv[9]|new[10]|new	_	_
3-34	221-224	for	abstract[9]	giv[9]	_	_
3-35	225-228	the	abstract[9]|time[12]	giv[9]|new[12]	_	_
3-36	229-233	last	abstract[9]|time[12]	giv[9]|new[12]	_	_
3-37	234-237	two	abstract[9]|time[12]	giv[9]|new[12]	_	_
3-38	238-245	decades	abstract[9]|time[12]	giv[9]|new[12]	_	_
3-39	246-247	.	_	_	_	_

#Text=Among several approaches used to create nanozymes , the self-assembly of thiolated ligands onto the surface of gold nanoparticles ( Au-NPs ) to obtain monolayer-protected gold clusters ( Au-MPCs ) has emerged as a powerful strategy .
4-1	248-253	Among	_	_	_	_
4-2	254-261	several	abstract[13]	new[13]	coref	15-23[144_13]
4-3	262-272	approaches	abstract[13]	new[13]	_	_
4-4	273-277	used	_	_	_	_
4-5	278-280	to	_	_	_	_
4-6	281-287	create	_	_	_	_
4-7	288-297	nanozymes	object[14]	giv[14]	_	_
4-8	298-299	,	object[14]	giv[14]	_	_
4-9	300-303	the	object[14]|substance[15]	giv[14]|new[15]	_	_
4-10	304-317	self-assembly	object[14]|substance[15]	giv[14]|new[15]	_	_
4-11	318-320	of	object[14]|substance[15]	giv[14]|new[15]	_	_
4-12	321-330	thiolated	object[14]|substance[15]	giv[14]|new[15]	_	_
4-13	331-338	ligands	object[14]|substance[15]	giv[14]|new[15]	_	_
4-14	339-343	onto	object[14]|substance[15]	giv[14]|new[15]	_	_
4-15	344-347	the	object[14]|substance[15]|place[16]	giv[14]|new[15]|new[16]	coref	5-10[25_16]
4-16	348-355	surface	object[14]|substance[15]|place[16]	giv[14]|new[15]|new[16]	_	_
4-17	356-358	of	object[14]|substance[15]|place[16]	giv[14]|new[15]|new[16]	_	_
4-18	359-363	gold	object[14]|substance[15]|place[16]|substance|abstract[18]	giv[14]|new[15]|new[16]|new|new[18]	appos|coref|appos|coref	4-21[0_18]|4-26|4-21[0_18]|4-26
4-19	364-377	nanoparticles	object[14]|substance[15]|place[16]|abstract[18]	giv[14]|new[15]|new[16]|new[18]	_	_
4-20	378-379	(	_	_	_	_
4-21	380-386	Au-NPs	abstract	giv	coref	5-13[27_0]
4-22	387-388	)	_	_	_	_
4-23	389-391	to	_	_	_	_
4-24	392-398	obtain	_	_	_	_
4-25	399-418	monolayer-protected	abstract[21]	new[21]	appos	4-29[0_21]
4-26	419-423	gold	substance|abstract[21]	giv|new[21]	coref	5-13
4-27	424-432	clusters	abstract[21]	new[21]	_	_
4-28	433-434	(	_	_	_	_
4-29	435-442	Au-MPCs	abstract	giv	_	_
4-30	443-444	)	_	_	_	_
4-31	445-448	has	_	_	_	_
4-32	449-456	emerged	_	_	_	_
4-33	457-459	as	_	_	_	_
4-34	460-461	a	_	_	_	_
4-35	462-470	powerful	_	_	_	_
4-36	471-479	strategy	_	_	_	_
4-37	480-481	.	_	_	_	_

#Text=In particular , the conjugation of peptides on to the surface of gold nanoparticles to yield peptide – gold nanoparticle conjugates ( Pep-Au-NPs ) expanded the possibilities for the design of artificial enzymes .
5-1	482-484	In	_	_	_	_
5-2	485-495	particular	_	_	_	_
5-3	496-497	,	_	_	_	_
5-4	498-501	the	abstract[23]	new[23]	_	_
5-5	502-513	conjugation	abstract[23]	new[23]	_	_
5-6	514-516	of	abstract[23]	new[23]	_	_
5-7	517-525	peptides	abstract[23]|substance	new[23]|new	coref	6-1
5-8	526-528	on	abstract[23]	new[23]	_	_
5-9	529-531	to	abstract[23]	new[23]	_	_
5-10	532-535	the	abstract[23]|object[25]	new[23]|giv[25]	_	_
5-11	536-543	surface	abstract[23]|object[25]	new[23]|giv[25]	_	_
5-12	544-546	of	abstract[23]|object[25]	new[23]|giv[25]	_	_
5-13	547-551	gold	abstract[23]|object[25]|substance|object[27]	new[23]|giv[25]|giv|giv[27]	coref|coref|coref|coref	5-19|7-6[0_27]|5-19|7-6[0_27]
5-14	552-565	nanoparticles	abstract[23]|object[25]|object[27]	new[23]|giv[25]|giv[27]	_	_
5-15	566-568	to	_	_	_	_
5-16	569-574	yield	_	_	_	_
5-17	575-582	peptide	substance	new	coref	6-9
5-18	583-584	–	_	_	_	_
5-19	585-589	gold	substance|object[31]	giv|new[31]	appos|appos	5-23[0_31]|5-23[0_31]
5-20	590-602	nanoparticle	quantity|object[31]	new|new[31]	_	_
5-21	603-613	conjugates	object[31]	new[31]	_	_
5-22	614-615	(	_	_	_	_
5-23	616-626	Pep-Au-NPs	object	giv	coref	10-9
5-24	627-628	)	_	_	_	_
5-25	629-637	expanded	_	_	_	_
5-26	638-641	the	abstract[33]	new[33]	_	_
5-27	642-655	possibilities	abstract[33]	new[33]	_	_
5-28	656-659	for	abstract[33]	new[33]	_	_
5-29	660-663	the	abstract[33]|abstract[34]	new[33]|new[34]	coref	6-13[41_34]
5-30	664-670	design	abstract[33]|abstract[34]	new[33]|new[34]	_	_
5-31	671-673	of	abstract[33]|abstract[34]	new[33]|new[34]	_	_
5-32	674-684	artificial	abstract[33]|abstract[34]|object[35]	new[33]|new[34]|new[35]	ana	6-13[0_35]
5-33	685-692	enzymes	abstract[33]|abstract[34]|object[35]	new[33]|new[34]|new[35]	_	_
5-34	693-694	.	_	_	_	_

#Text=Peptides are available at low cost by solid-phase peptide synthesis , and their modular design paired with the available repertoire of natural and non-natural amino acids allows for facile diversification of functional groups , and thus the resulting catalytic activities and substrate specificities of the peptide shell .
6-1	695-703	Peptides	object	giv	coref	7-4[53_0]
6-2	704-707	are	_	_	_	_
6-3	708-717	available	_	_	_	_
6-4	718-720	at	_	_	_	_
6-5	721-724	low	abstract[37]	new[37]	_	_
6-6	725-729	cost	abstract[37]	new[37]	_	_
6-7	730-732	by	abstract[37]	new[37]	_	_
6-8	733-744	solid-phase	abstract[37]|abstract[39]	new[37]|new[39]	coref	16-31[157_39]
6-9	745-752	peptide	abstract[37]|abstract|abstract[39]	new[37]|giv|new[39]	coref	6-46
6-10	753-762	synthesis	abstract[37]|abstract[39]	new[37]|new[39]	_	_
6-11	763-764	,	_	_	_	_
6-12	765-768	and	_	_	_	_
6-13	769-774	their	object|abstract[41]	giv|giv[41]	coref|coref	10-4[75_41]|10-4[75_41]
6-14	775-782	modular	abstract[41]	giv[41]	_	_
6-15	783-789	design	abstract[41]	giv[41]	_	_
6-16	790-796	paired	_	_	_	_
6-17	797-801	with	_	_	_	_
6-18	802-805	the	abstract[42]	new[42]	_	_
6-19	806-815	available	abstract[42]	new[42]	_	_
6-20	816-826	repertoire	abstract[42]	new[42]	_	_
6-21	827-829	of	abstract[42]	new[42]	_	_
6-22	830-837	natural	abstract[42]|substance[44]	new[42]|new[44]	_	_
6-23	838-841	and	abstract[42]|substance[44]	new[42]|new[44]	_	_
6-24	842-853	non-natural	abstract[42]|substance[44]	new[42]|new[44]	_	_
6-25	854-859	amino	abstract[42]|object|substance[44]	new[42]|new|new[44]	_	_
6-26	860-865	acids	abstract[42]|substance[44]	new[42]|new[44]	_	_
6-27	866-872	allows	_	_	_	_
6-28	873-876	for	_	_	_	_
6-29	877-883	facile	abstract[45]	new[45]	_	_
6-30	884-899	diversification	abstract[45]	new[45]	_	_
6-31	900-902	of	abstract[45]	new[45]	_	_
6-32	903-913	functional	abstract[45]|abstract[46]	new[45]|new[46]	coref	8-15[66_46]
6-33	914-920	groups	abstract[45]|abstract[46]	new[45]|new[46]	_	_
6-34	921-922	,	_	_	_	_
6-35	923-926	and	_	_	_	_
6-36	927-931	thus	abstract[47]	new[47]	_	_
6-37	932-935	the	abstract[47]	new[47]	_	_
6-38	936-945	resulting	abstract[47]	new[47]	_	_
6-39	946-955	catalytic	abstract[47]	new[47]	_	_
6-40	956-966	activities	abstract[47]	new[47]	_	_
6-41	967-970	and	_	_	_	_
6-42	971-980	substrate	person|abstract[49]	new|new[49]	coref|coref	8-20|8-20
6-43	981-994	specificities	abstract[49]	new[49]	_	_
6-44	995-997	of	abstract[49]	new[49]	_	_
6-45	998-1001	the	abstract[49]|object[51]	new[49]|new[51]	_	_
6-46	1002-1009	peptide	abstract[49]|abstract|object[51]	new[49]|giv|new[51]	coref	7-10
6-47	1010-1015	shell	abstract[49]|object[51]	new[49]|new[51]	_	_
6-48	1016-1017	.	_	_	_	_

#Text=The conjunction of peptides and Au-NPs leads to dense peptide monolayers in which new hydrogen bond and/or charge interactions between individual peptides are established .
7-1	1018-1021	The	abstract[52]	new[52]	_	_
7-2	1022-1033	conjunction	abstract[52]	new[52]	_	_
7-3	1034-1036	of	abstract[52]	new[52]	_	_
7-4	1037-1045	peptides	abstract[52]|substance[53]	new[52]|giv[53]	coref	7-21[60_53]
7-5	1046-1049	and	abstract[52]|substance[53]	new[52]|giv[53]	_	_
7-6	1050-1056	Au-NPs	abstract[52]|substance[53]|abstract	new[52]|giv[53]|giv	_	_
7-7	1057-1062	leads	_	_	_	_
7-8	1063-1065	to	_	_	_	_
7-9	1066-1071	dense	object[56]	new[56]	_	_
7-10	1072-1079	peptide	place|object[56]	giv|new[56]	coref	9-15[73_0]
7-11	1080-1090	monolayers	object[56]	new[56]	_	_
7-12	1091-1093	in	_	_	_	_
7-13	1094-1099	which	_	_	_	_
7-14	1100-1103	new	abstract[58]	new[58]	ana	8-1[0_58]
7-15	1104-1112	hydrogen	substance|abstract[58]	new|new[58]	_	_
7-16	1113-1117	bond	abstract[58]	new[58]	_	_
7-17	1118-1124	and/or	_	_	_	_
7-18	1125-1131	charge	_	_	_	_
7-19	1132-1144	interactions	abstract[59]	new[59]	_	_
7-20	1145-1152	between	abstract[59]	new[59]	_	_
7-21	1153-1163	individual	abstract[59]|substance[60]	new[59]|giv[60]	_	_
7-22	1164-1172	peptides	abstract[59]|substance[60]	new[59]|giv[60]	_	_
7-23	1173-1176	are	_	_	_	_
7-24	1177-1188	established	_	_	_	_
7-25	1189-1190	.	_	_	_	_

#Text=This enables known enzyme-like effects , such as the perturbation of pKa values of functional groups and cooperativity in substrate binding , and can even lead to new catalytic mechanisms .
8-1	1191-1195	This	abstract	giv	_	_
8-2	1196-1203	enables	_	_	_	_
8-3	1204-1209	known	abstract[62]	new[62]	coref	9-3[71_62]
8-4	1210-1221	enzyme-like	abstract[62]	new[62]	_	_
8-5	1222-1229	effects	abstract[62]	new[62]	_	_
8-6	1230-1231	,	abstract[62]	new[62]	_	_
8-7	1232-1236	such	abstract[62]	new[62]	_	_
8-8	1237-1239	as	abstract[62]	new[62]	_	_
8-9	1240-1243	the	abstract[62]|abstract[63]	new[62]|new[63]	_	_
8-10	1244-1256	perturbation	abstract[62]|abstract[63]	new[62]|new[63]	_	_
8-11	1257-1259	of	abstract[62]|abstract[63]	new[62]|new[63]	_	_
8-12	1260-1263	pKa	abstract[62]|abstract[63]|quantity|abstract[65]	new[62]|new[63]|new|new[65]	coref|coref	13-40[122_0]|13-40[122_0]
8-13	1264-1270	values	abstract[62]|abstract[63]|abstract[65]	new[62]|new[63]|new[65]	_	_
8-14	1271-1273	of	abstract[62]|abstract[63]|abstract[65]	new[62]|new[63]|new[65]	_	_
8-15	1274-1284	functional	abstract[62]|abstract[63]|abstract[65]|abstract[66]	new[62]|new[63]|new[65]|giv[66]	_	_
8-16	1285-1291	groups	abstract[62]|abstract[63]|abstract[65]|abstract[66]	new[62]|new[63]|new[65]|giv[66]	_	_
8-17	1292-1295	and	abstract[62]|abstract[63]|abstract[65]|abstract[66]	new[62]|new[63]|new[65]|giv[66]	_	_
8-18	1296-1309	cooperativity	abstract[62]|abstract[63]|abstract[65]|abstract[66]|event[67]	new[62]|new[63]|new[65]|giv[66]|new[67]	_	_
8-19	1310-1312	in	abstract[62]|abstract[63]|abstract[65]|abstract[66]|event[67]	new[62]|new[63]|new[65]|giv[66]|new[67]	_	_
8-20	1313-1322	substrate	abstract[62]|abstract[63]|abstract[65]|abstract[66]|event[67]|object|event[69]	new[62]|new[63]|new[65]|giv[66]|new[67]|giv|new[69]	_	_
8-21	1323-1330	binding	abstract[62]|abstract[63]|abstract[65]|abstract[66]|event[67]|event[69]	new[62]|new[63]|new[65]|giv[66]|new[67]|new[69]	_	_
8-22	1331-1332	,	_	_	_	_
8-23	1333-1336	and	_	_	_	_
8-24	1337-1340	can	_	_	_	_
8-25	1341-1345	even	_	_	_	_
8-26	1346-1350	lead	_	_	_	_
8-27	1351-1353	to	_	_	_	_
8-28	1354-1357	new	abstract[70]	new[70]	_	_
8-29	1358-1367	catalytic	abstract[70]	new[70]	_	_
8-30	1368-1378	mechanisms	abstract[70]	new[70]	_	_
8-31	1379-1380	.	_	_	_	_

#Text=Altogether , these effects can greatly improve the catalytic performance of a conjugated versus an unconjugated peptide .
9-1	1381-1391	Altogether	_	_	_	_
9-2	1392-1393	,	_	_	_	_
9-3	1394-1399	these	abstract[71]	giv[71]	_	_
9-4	1400-1407	effects	abstract[71]	giv[71]	_	_
9-5	1408-1411	can	_	_	_	_
9-6	1412-1419	greatly	_	_	_	_
9-7	1420-1427	improve	_	_	_	_
9-8	1428-1431	the	abstract[72]	new[72]	_	_
9-9	1432-1441	catalytic	abstract[72]	new[72]	_	_
9-10	1442-1453	performance	abstract[72]	new[72]	_	_
9-11	1454-1456	of	abstract[72]	new[72]	_	_
9-12	1457-1458	a	abstract[72]	new[72]	_	_
9-13	1459-1469	conjugated	abstract[72]	new[72]	_	_
9-14	1470-1476	versus	_	_	_	_
9-15	1477-1479	an	substance[73]	giv[73]	_	_
9-16	1480-1492	unconjugated	substance[73]	giv[73]	_	_
9-17	1493-1500	peptide	substance[73]	giv[73]	_	_
9-18	1501-1502	.	_	_	_	_

#Text=To date , the design and application of Pep-Au-NPs have been limited to organic esterase chemistry , in which catalysis is mediated by a His-imidazole .
10-1	1503-1505	To	_	_	_	_
10-2	1506-1510	date	time	new	_	_
10-3	1511-1512	,	_	_	_	_
10-4	1513-1516	the	abstract[75]|abstract[76]	giv[75]|new[76]	coref|coref	16-28[156_76]|16-28[156_76]
10-5	1517-1523	design	abstract[75]|abstract[76]	giv[75]|new[76]	_	_
10-6	1524-1527	and	abstract[76]	new[76]	_	_
10-7	1528-1539	application	abstract[76]|abstract[77]	new[76]|new[77]	coref	15-2[137_77]
10-8	1540-1542	of	abstract[76]|abstract[77]	new[76]|new[77]	_	_
10-9	1543-1553	Pep-Au-NPs	abstract[76]|abstract[77]|object	new[76]|new[77]|giv	coref	16-12
10-10	1554-1558	have	_	_	_	_
10-11	1559-1563	been	_	_	_	_
10-12	1564-1571	limited	_	_	_	_
10-13	1572-1574	to	_	_	_	_
10-14	1575-1582	organic	abstract[80]	new[80]	_	_
10-15	1583-1591	esterase	object|abstract[80]	new|new[80]	_	_
10-16	1592-1601	chemistry	abstract[80]	new[80]	_	_
10-17	1602-1603	,	_	_	_	_
10-18	1604-1606	in	_	_	_	_
10-19	1607-1612	which	abstract[81]	new[81]	_	_
10-20	1613-1622	catalysis	abstract[81]	new[81]	_	_
10-21	1623-1625	is	_	_	_	_
10-22	1626-1634	mediated	_	_	_	_
10-23	1635-1637	by	_	_	_	_
10-24	1638-1639	a	substance[82]	new[82]	_	_
10-25	1640-1653	His-imidazole	substance[82]	new[82]	_	_
10-26	1654-1655	.	_	_	_	_

#Text=Considering the fact that zinc metalloenzymes perform numerous other types of reactions in nature , including phosphodiester and amide hydrolysis as well as the ( de)hydrogenation of alcohols , it is of great interest to reconstitute such transformations in vitro by developing appropriate robust synthetic systems .
11-1	1656-1667	Considering	_	_	_	_
11-2	1668-1671	the	abstract[83]	new[83]	_	_
11-3	1672-1676	fact	abstract[83]	new[83]	_	_
11-4	1677-1681	that	abstract[83]	new[83]	_	_
11-5	1682-1686	zinc	abstract[83]|substance|substance[85]	new[83]|new|new[85]	coref|coref	12-13|12-13
11-6	1687-1701	metalloenzymes	abstract[83]|substance[85]	new[83]|new[85]	_	_
11-7	1702-1709	perform	abstract[83]	new[83]	_	_
11-8	1710-1718	numerous	abstract[83]|place[86]	new[83]|new[86]	_	_
11-9	1719-1724	other	abstract[83]|place[86]	new[83]|new[86]	_	_
11-10	1725-1730	types	abstract[83]|place[86]	new[83]|new[86]	_	_
11-11	1731-1733	of	abstract[83]|place[86]	new[83]|new[86]	_	_
11-12	1734-1743	reactions	abstract[83]|place[86]|event[87]	new[83]|new[86]|new[87]	_	_
11-13	1744-1746	in	abstract[83]|place[86]|event[87]	new[83]|new[86]|new[87]	_	_
11-14	1747-1753	nature	abstract[83]|place[86]|event[87]|abstract	new[83]|new[86]|new[87]|new	_	_
11-15	1754-1755	,	abstract[83]|place[86]|event[87]	new[83]|new[86]|new[87]	_	_
11-16	1756-1765	including	abstract[83]|place[86]|event[87]	new[83]|new[86]|new[87]	_	_
11-17	1766-1780	phosphodiester	abstract[83]|place[86]|event[87]|substance|substance[91]	new[83]|new[86]|new[87]|new|new[91]	_	_
11-18	1781-1784	and	abstract[83]|place[86]|event[87]|substance[91]	new[83]|new[86]|new[87]|new[91]	_	_
11-19	1785-1790	amide	abstract[83]|place[86]|event[87]|substance|substance[91]	new[83]|new[86]|new[87]|new|new[91]	_	_
11-20	1791-1801	hydrolysis	abstract[83]|place[86]|event[87]|substance[91]	new[83]|new[86]|new[87]|new[91]	_	_
11-21	1802-1804	as	abstract[83]	new[83]	_	_
11-22	1805-1809	well	abstract[83]	new[83]	_	_
11-23	1810-1812	as	abstract[83]	new[83]	_	_
11-24	1813-1816	the	abstract[83]|event[92]	new[83]|new[92]	ana	11-30[0_92]
11-25	1817-1818	(	abstract[83]|event[92]	new[83]|new[92]	_	_
11-26	1819-1835	de)hydrogenation	abstract[83]|event[92]	new[83]|new[92]	_	_
11-27	1836-1838	of	abstract[83]|event[92]	new[83]|new[92]	_	_
11-28	1839-1847	alcohols	abstract[83]|event[92]|substance	new[83]|new[92]|new	_	_
11-29	1848-1849	,	_	_	_	_
11-30	1850-1852	it	event	giv	_	_
11-31	1853-1855	is	_	_	_	_
11-32	1856-1858	of	_	_	_	_
11-33	1859-1864	great	abstract[95]	new[95]	coref	15-6[139_95]
11-34	1865-1873	interest	abstract[95]	new[95]	_	_
11-35	1874-1876	to	_	_	_	_
11-36	1877-1889	reconstitute	_	_	_	_
11-37	1890-1894	such	abstract[96]	new[96]	_	_
11-38	1895-1910	transformations	abstract[96]	new[96]	_	_
11-39	1911-1913	in	abstract[96]	new[96]	_	_
11-40	1914-1919	vitro	abstract[96]	new[96]	_	_
11-41	1920-1922	by	_	_	_	_
11-42	1923-1933	developing	_	_	_	_
11-43	1934-1945	appropriate	abstract[97]	new[97]	coref	14-26[136_97]
11-44	1946-1952	robust	abstract[97]	new[97]	_	_
11-45	1953-1962	synthetic	abstract[97]	new[97]	_	_
11-46	1963-1970	systems	abstract[97]	new[97]	_	_
11-47	1971-1972	.	_	_	_	_

#Text=For example , carbonic anhydrase ( CA ) is a naturally occurring zinc metalloenzyme that efficiently and reversibly catalyzes the hydration of CO2 into hydrogen carbonate ( HCO3− ) .
12-1	1973-1976	For	_	_	_	_
12-2	1977-1984	example	_	_	_	_
12-3	1985-1986	,	_	_	_	_
12-4	1987-1995	carbonic	abstract|substance[99]	new|new[99]	coref|coref|coref|coref	12-10[102_99]|16-38|12-10[102_99]|16-38
12-5	1996-2005	anhydrase	substance[99]	new[99]	_	_
12-6	2006-2007	(	_	_	_	_
12-7	2008-2010	CA	object	new	ana	13-1
12-8	2011-2012	)	_	_	_	_
12-9	2013-2015	is	_	_	_	_
12-10	2016-2017	a	substance[102]	giv[102]	coref	16-33[159_102]
12-11	2018-2027	naturally	substance[102]	giv[102]	_	_
12-12	2028-2037	occurring	substance[102]	giv[102]	_	_
12-13	2038-2042	zinc	substance|substance[102]	giv|giv[102]	coref	13-6[110_0]
12-14	2043-2056	metalloenzyme	substance[102]	giv[102]	_	_
12-15	2057-2061	that	_	_	_	_
12-16	2062-2073	efficiently	_	_	_	_
12-17	2074-2077	and	_	_	_	_
12-18	2078-2088	reversibly	_	_	_	_
12-19	2089-2098	catalyzes	_	_	_	_
12-20	2099-2102	the	substance[103]	new[103]	_	_
12-21	2103-2112	hydration	substance[103]	new[103]	_	_
12-22	2113-2115	of	substance[103]	new[103]	_	_
12-23	2116-2119	CO2	substance[103]|substance	new[103]|new	coref	13-56
12-24	2120-2124	into	_	_	_	_
12-25	2125-2133	hydrogen	abstract[105]	new[105]	appos	12-28[0_105]
12-26	2134-2143	carbonate	abstract[105]	new[105]	_	_
12-27	2144-2145	(	_	_	_	_
12-28	2146-2151	HCO3−	abstract	giv	coref	13-65
12-29	2152-2153	)	_	_	_	_
12-30	2154-2155	.	_	_	_	_

#Text=Its high activity originates from its zinc ( Zn(II ) ) containing active site , in which three histidine imidazole moieties coordinate a Zn(II)-ion leaving a vacant space for the association of a water molecule . Zn(II ) lowers the pKa of the bound water and forms a highly nucleophilic hydroxide species which reacts with CO2 , bound in close proximity , to yield HCO3− .
13-1	2156-2159	Its	object|abstract[108]	giv|new[108]	ana|coref|ana|coref	13-6|16-38[162_108]|13-6|16-38[162_108]
13-2	2160-2164	high	abstract[108]	new[108]	_	_
13-3	2165-2173	activity	abstract[108]	new[108]	_	_
13-4	2174-2184	originates	_	_	_	_
13-5	2185-2189	from	_	_	_	_
13-6	2190-2193	its	substance|abstract[110]	giv|giv[110]	appos|appos	13-9[0_110]|13-9[0_110]
13-7	2194-2198	zinc	abstract[110]	giv[110]	_	_
13-8	2199-2200	(	_	_	_	_
13-9	2201-2206	Zn(II	abstract	giv	coref	13-37
13-10	2207-2208	)	_	_	_	_
13-11	2209-2210	)	_	_	_	_
13-12	2211-2221	containing	_	_	_	_
13-13	2222-2228	active	place[112]	new[112]	_	_
13-14	2229-2233	site	place[112]	new[112]	_	_
13-15	2234-2235	,	_	_	_	_
13-16	2236-2238	in	_	_	_	_
13-17	2239-2244	which	_	_	_	_
13-18	2245-2250	three	substance[115]	new[115]	_	_
13-19	2251-2260	histidine	substance|substance[115]	new|new[115]	_	_
13-20	2261-2270	imidazole	object|substance[115]	new|new[115]	_	_
13-21	2271-2279	moieties	substance[115]	new[115]	_	_
13-22	2280-2290	coordinate	_	_	_	_
13-23	2291-2292	a	substance[116]	new[116]	_	_
13-24	2293-2303	Zn(II)-ion	substance[116]	new[116]	_	_
13-25	2304-2311	leaving	_	_	_	_
13-26	2312-2313	a	place[117]	new[117]	_	_
13-27	2314-2320	vacant	place[117]	new[117]	_	_
13-28	2321-2326	space	place[117]	new[117]	_	_
13-29	2327-2330	for	_	_	_	_
13-30	2331-2334	the	event[118]	new[118]	_	_
13-31	2335-2346	association	event[118]	new[118]	_	_
13-32	2347-2349	of	event[118]	new[118]	_	_
13-33	2350-2351	a	event[118]|substance[120]	new[118]|new[120]	_	_
13-34	2352-2357	water	event[118]|substance|substance[120]	new[118]|new|new[120]	coref	13-43[123_0]
13-35	2358-2366	molecule	event[118]|substance[120]	new[118]|new[120]	_	_
13-36	2367-2368	.	_	_	_	_
13-37	2369-2374	Zn(II	substance	giv	_	_
13-38	2375-2376	)	_	_	_	_
13-39	2377-2383	lowers	_	_	_	_
13-40	2384-2387	the	quantity[122]	giv[122]	_	_
13-41	2388-2391	pKa	quantity[122]	giv[122]	_	_
13-42	2392-2394	of	quantity[122]	giv[122]	_	_
13-43	2395-2398	the	quantity[122]|substance[123]	giv[122]|giv[123]	_	_
13-44	2399-2404	bound	quantity[122]|substance[123]	giv[122]|giv[123]	_	_
13-45	2405-2410	water	quantity[122]|substance[123]	giv[122]|giv[123]	_	_
13-46	2411-2414	and	_	_	_	_
13-47	2415-2420	forms	_	_	_	_
13-48	2421-2422	a	abstract[125]	new[125]	_	_
13-49	2423-2429	highly	abstract[125]	new[125]	_	_
13-50	2430-2442	nucleophilic	abstract[125]	new[125]	_	_
13-51	2443-2452	hydroxide	animal|abstract[125]	new|new[125]	_	_
13-52	2453-2460	species	abstract[125]	new[125]	_	_
13-53	2461-2466	which	_	_	_	_
13-54	2467-2473	reacts	_	_	_	_
13-55	2474-2478	with	_	_	_	_
13-56	2479-2482	CO2	substance	giv	coref	15-13
13-57	2483-2484	,	_	_	_	_
13-58	2485-2490	bound	_	_	_	_
13-59	2491-2493	in	_	_	_	_
13-60	2494-2499	close	abstract[127]	new[127]	_	_
13-61	2500-2509	proximity	abstract[127]	new[127]	_	_
13-62	2510-2511	,	_	_	_	_
13-63	2512-2514	to	_	_	_	_
13-64	2515-2520	yield	_	_	_	_
13-65	2521-2526	HCO3−	substance	giv	_	_
13-66	2527-2528	.	_	_	_	_

#Text=CA isoforms have been extensively studied due to their clinical importance as drug targets and artificial lungs , and their great potential as catalysts in carbon capture systems .
14-1	2529-2531	CA	_	_	_	_
14-2	2532-2540	isoforms	abstract	new	ana	14-9
14-3	2541-2545	have	_	_	_	_
14-4	2546-2550	been	_	_	_	_
14-5	2551-2562	extensively	_	_	_	_
14-6	2563-2570	studied	_	_	_	_
14-7	2571-2574	due	_	_	_	_
14-8	2575-2577	to	_	_	_	_
14-9	2578-2583	their	abstract|abstract[131]	giv|new[131]	ana|ana	14-20|14-20
14-10	2584-2592	clinical	abstract[131]	new[131]	_	_
14-11	2593-2603	importance	abstract[131]	new[131]	_	_
14-12	2604-2606	as	abstract[131]	new[131]	_	_
14-13	2607-2611	drug	abstract[131]|substance	new[131]|new	_	_
14-14	2612-2619	targets	abstract[131]	new[131]	_	_
14-15	2620-2623	and	abstract[131]	new[131]	_	_
14-16	2624-2634	artificial	abstract[131]	new[131]	_	_
14-17	2635-2640	lungs	abstract[131]	new[131]	_	_
14-18	2641-2642	,	abstract[131]	new[131]	_	_
14-19	2643-2646	and	abstract[131]	new[131]	_	_
14-20	2647-2652	their	abstract[131]|abstract	new[131]|giv	_	_
14-21	2653-2658	great	abstract[131]	new[131]	_	_
14-22	2659-2668	potential	abstract[131]	new[131]	_	_
14-23	2669-2671	as	abstract[131]	new[131]	_	_
14-24	2672-2681	catalysts	abstract[131]	new[131]	_	_
14-25	2682-2684	in	abstract[131]	new[131]	_	_
14-26	2685-2691	carbon	abstract[131]|substance|abstract[136]	new[131]|new|giv[136]	_	_
14-27	2692-2699	capture	abstract[131]|event|abstract[136]	new[131]|new|giv[136]	_	_
14-28	2700-2707	systems	abstract[131]|abstract[136]	new[131]|giv[136]	_	_
14-29	2708-2709	.	_	_	_	_

#Text=Especially the latter application drove our interest , as the emission of CO2 and the associated anthropogenic climate change steadily proceeds and new approaches for the absorption of CO2 become increasingly urgent .
15-1	2710-2720	Especially	_	_	_	_
15-2	2721-2724	the	abstract[137]	giv[137]	_	_
15-3	2725-2731	latter	abstract[137]	giv[137]	_	_
15-4	2732-2743	application	abstract[137]	giv[137]	_	_
15-5	2744-2749	drove	_	_	_	_
15-6	2750-2753	our	person|abstract[139]	acc|giv[139]	ana|ana	16-6|16-6
15-7	2754-2762	interest	abstract[139]	giv[139]	_	_
15-8	2763-2764	,	_	_	_	_
15-9	2765-2767	as	_	_	_	_
15-10	2768-2771	the	_	_	_	_
15-11	2772-2780	emission	_	_	_	_
15-12	2781-2783	of	_	_	_	_
15-13	2784-2787	CO2	substance	giv	coref	15-29
15-14	2788-2791	and	_	_	_	_
15-15	2792-2795	the	abstract[143]	new[143]	_	_
15-16	2796-2806	associated	abstract[143]	new[143]	_	_
15-17	2807-2820	anthropogenic	abstract|abstract[143]	new|new[143]	_	_
15-18	2821-2828	climate	abstract|abstract[143]	new|new[143]	_	_
15-19	2829-2835	change	abstract[143]	new[143]	_	_
15-20	2836-2844	steadily	_	_	_	_
15-21	2845-2853	proceeds	_	_	_	_
15-22	2854-2857	and	_	_	_	_
15-23	2858-2861	new	abstract[144]	giv[144]	_	_
15-24	2862-2872	approaches	abstract[144]	giv[144]	_	_
15-25	2873-2876	for	abstract[144]	giv[144]	_	_
15-26	2877-2880	the	abstract[144]|abstract[145]	giv[144]|new[145]	coref	16-22[0_145]
15-27	2881-2891	absorption	abstract[144]|abstract[145]	giv[144]|new[145]	_	_
15-28	2892-2894	of	abstract[144]|abstract[145]	giv[144]|new[145]	_	_
15-29	2895-2898	CO2	abstract[144]|abstract[145]|substance	giv[144]|new[145]|giv	coref	16-21[153_0]
15-30	2899-2905	become	_	_	_	_
15-31	2906-2918	increasingly	_	_	_	_
15-32	2919-2925	urgent	_	_	_	_
15-33	2926-2927	.	_	_	_	_

#Text=In order to further increase our understanding of the design of Pep-Au-NPs , and to present a new approach for the absorption CO2 , we herein describe the design and synthesis of the first Pep-Au-NP metalloenzyme mimicking carbonic anhydrase activity .
16-1	2928-2930	In	_	_	_	_
16-2	2931-2936	order	_	_	_	_
16-3	2937-2939	to	_	_	_	_
16-4	2940-2947	further	_	_	_	_
16-5	2948-2956	increase	_	_	_	_
16-6	2957-2960	our	person|abstract[148]	giv|new[148]	ana|ana	16-25|16-25
16-7	2961-2974	understanding	abstract[148]	new[148]	_	_
16-8	2975-2977	of	abstract[148]	new[148]	_	_
16-9	2978-2981	the	abstract[148]|abstract[149]	new[148]|new[149]	coref	16-28[155_149]
16-10	2982-2988	design	abstract[148]|abstract[149]	new[148]|new[149]	_	_
16-11	2989-2991	of	abstract[148]|abstract[149]	new[148]|new[149]	_	_
16-12	2992-3002	Pep-Au-NPs	abstract[148]|abstract[149]|object	new[148]|new[149]|giv	_	_
16-13	3003-3004	,	_	_	_	_
16-14	3005-3008	and	_	_	_	_
16-15	3009-3011	to	_	_	_	_
16-16	3012-3019	present	_	_	_	_
16-17	3020-3021	a	abstract[151]	new[151]	_	_
16-18	3022-3025	new	abstract[151]	new[151]	_	_
16-19	3026-3034	approach	abstract[151]	new[151]	_	_
16-20	3035-3038	for	abstract[151]	new[151]	_	_
16-21	3039-3042	the	abstract[151]|substance[153]	new[151]|giv[153]	_	_
16-22	3043-3053	absorption	abstract[151]|abstract|substance[153]	new[151]|giv|giv[153]	_	_
16-23	3054-3057	CO2	abstract[151]|substance[153]	new[151]|giv[153]	_	_
16-24	3058-3059	,	_	_	_	_
16-25	3060-3062	we	person	giv	_	_
16-26	3063-3069	herein	_	_	_	_
16-27	3070-3078	describe	_	_	_	_
16-28	3079-3082	the	abstract[155]|abstract[156]	giv[155]|giv[156]	_	_
16-29	3083-3089	design	abstract[155]|abstract[156]	giv[155]|giv[156]	_	_
16-30	3090-3093	and	abstract[156]	giv[156]	_	_
16-31	3094-3103	synthesis	abstract[156]|abstract[157]	giv[156]|giv[157]	_	_
16-32	3104-3106	of	abstract[156]|abstract[157]	giv[156]|giv[157]	_	_
16-33	3107-3110	the	abstract[156]|abstract[157]|substance[159]	giv[156]|giv[157]|giv[159]	coref	16-39[0_159]
16-34	3111-3116	first	abstract[156]|abstract[157]|substance[159]	giv[156]|giv[157]|giv[159]	_	_
16-35	3117-3126	Pep-Au-NP	abstract[156]|abstract[157]|abstract|substance[159]	giv[156]|giv[157]|new|giv[159]	_	_
16-36	3127-3140	metalloenzyme	abstract[156]|abstract[157]|substance[159]	giv[156]|giv[157]|giv[159]	_	_
16-37	3141-3150	mimicking	_	_	_	_
16-38	3151-3159	carbonic	abstract|abstract[162]	giv|giv[162]	_	_
16-39	3160-3169	anhydrase	substance|abstract[162]	giv|giv[162]	_	_
16-40	3170-3178	activity	abstract[162]	giv[162]	_	_
16-41	3179-3180	.	_	_	_	_
